Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.24.1.1.u2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue $ 682 $ 22
Cost of revenue, excluding depreciation and amortization (1,636) (31)
Depreciation and amortization (212) (182)
Research and development (756) (541)
General and administrative (1,783) (3,394)
Loss from operations (3,705) (4,126)
Other income (expense):    
Interest expense (860) (2,017)
Loss on extinguishment of warrant liability 0 (504)
Gain on issuance of convertible notes 0 64
Change in fair value of warrants (23) 5,606
Change in fair value of notes 0 (117)
Other expense (24) (1,206)
Total other income (expense) (907) 1,826
Loss before income taxes (4,612) (2,300)
Income tax expense 0 0
Net loss (4,612) (2,300)
Deemed dividend on Series D preferred stock 0 (6)
Net loss attributable to common stockholders $ (4,895) $ (2,416)
Net loss per share attributable to common stockholders (in dollars per share) $ (0.13) $ (4.88)
Weighted average shares outstanding, basic and diluted:    
Weighted average shares outstanding, basic (in shares) 36,675,540 494,918
Weighted average shares outstanding, diluted (in shares) 36,675,540 494,918
Series A Preferred Stock    
Other income (expense):    
Cumulative dividends $ (5) $ (4)
Series B Preferred Stock    
Other income (expense):    
Cumulative dividends (29) (20)
Series C Preferred Stock    
Other income (expense):    
Cumulative dividends (10) 0
Series D Preferred Stock    
Other income (expense):    
Cumulative dividends 0 (86)
Series F Preferred Stock    
Other income (expense):    
Cumulative dividends (178) 0
Series F-1 Preferred Stock    
Other income (expense):    
Cumulative dividends (26) 0
Series F-2 Preferred Stock    
Other income (expense):    
Cumulative dividends $ (35)